Salivary glands as the primary dose-limiting organ: an integrated dosimetry, efficacy, and toxicity study of &lt;sup&gt;225&lt;/sup&gt;Ac-PSMA-617 in prostate cancer xenografts. The gene discussed is FOLH1; the disease is prostate carcinoma.